These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5647240)

  • 1. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue reaction in ovarian carcinoma after cyclophosphamide (Endoxan) therapy].
    Engeler V; Hanski W
    Pathol Microbiol (Basel); 1969; 33(3):153-60. PubMed ID: 5350583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 4. Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
    Volm T; Pfaff P; Gnann R; Kreienberg R
    Gynecol Oncol; 2001 Jul; 82(1):197-9. PubMed ID: 11426986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 6. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S; Richter K; Ehrhart H; Penning W; Meister P; Schmidt D; Götz A
    Fortschr Med; 1975 Oct; 93(28):1309-12. PubMed ID: 1228086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple massive-dose drug therapy in combined treatment of advanced ovarian carcinoma.
    Vahrson H
    Geburtshilfe Frauenheilkd; 1973 Apr; 33(4):293-6. PubMed ID: 4196905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endoxan in ovarian cancer].
    Campodónico I; Soldati A; Rodríguez A
    Rev Chil Obstet Ginecol; 1974; 39(3):87-9. PubMed ID: 4620179
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intratumor chemotherapy of patients with cancer of the ovaries].
    Vinokurov VL; Mitrokhina MV
    Vopr Onkol; 1983; 29(8):58-61. PubMed ID: 6310891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    Samaritani R; Corrado G; Vizza E; Sbiroli C
    BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
    Brandl K
    Zentralbl Gynakol; 1970 Feb; 92(8):233-9. PubMed ID: 5505972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclophosphamide in severe rheumatoid polyarthritis. Results from a preliminary trial on 10 cases].
    Auquier L; Henrard JC; Siaud JR
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):775-9. PubMed ID: 5152710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic, clinical and histological factors related to the survival of patients with advanced ovarian carcinoma.
    Kauppila A; Kivinen S; Mäkilä UM; Järvinen PA
    Ann Chir Gynaecol; 1981; 70(3):91-5. PubMed ID: 7325582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclophosphamide with dextran as a carrier in the therapy of ovarian neoplasms. Clinical trial].
    Cadenelli GP; Spreafichi F
    Quad Clin Ostet Ginecol; 1966 Oct; 21(10):686-9. PubMed ID: 5996154
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide.
    Young RC; Canellos GP; Chabner BA; Schein PS; Hubbard SP; DeVita VT
    Gynecol Oncol; 1974 Dec; 2(4):489-97. PubMed ID: 4376998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early results of polychemotherapy in advanced ovarian tumors].
    Rózewicki S; Rzepka I; Górski H
    Ginekol Pol; 1979 Nov; 50(11):953-6. PubMed ID: 544354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.